Payment for Positron Emission Tomography Scans in CMS-Approved Clinical Trials and Coverage With Evidence Development - Use of QR and QV Modifiers
Guidance for services performed on or after January 28, 2005, carrier claims, other than inpatient, for PET scans for neurodegenerative diseases submitted in conjunction with a Centers for Medicare & Medicaid Services (CMS)-approved clinical trial (see Pub. 100-03, National Coverage Determinations (NCD) Manual, section 220.6.13), will require the appropriate CPT code and the QR modifier, which replaces the QV modifier previously indicated in Transmittal 527, dated April 15, 2005.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: May 19, 2006
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.